The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT06059664
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT06059664
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06059664. Randomized; quadruple masking; primary purpose treatment. Start 2024-04-23 (actual); primary completion 2027-03-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
- Condition
- Kidney Transplant; Complications
- Intervention (Drug)
- Finerenone Oral Tablet
- Intervention (Drug)
- Placebo
- Lead sponsor
- University of North Carolina, Chapel Hill
- Collaborator
- Bayer
- Collaborator
- Weill Medical College of Cornell University
- Collaborator
- University of Cincinnati
Record details
- Record id
cardio:ct-nct06059664- Content hash
4f39e19420ca2991b37853f4969cfa89bf51f0fe1ff7a13d5e255a3d3194f988